Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.

Watt F, Watanabe R, Yang W, Agren N, Arvidsson Y, Funa K.

Cancer Gene Ther. 2007 Mar;14(3):287-96. Epub 2006 Nov 24.

PMID:
17124508
[PubMed - indexed for MEDLINE]
2.

Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase.

Arvidsson Y, Sumantran V, Watt F, Uramoto H, Funa K.

Pediatr Blood Cancer. 2005 Jan;44(1):77-84.

PMID:
15390277
[PubMed - indexed for MEDLINE]
3.

Activity of a novel PDGF beta-receptor enhancer during the cell cycle and upon differentiation of neuroblastoma.

Kaneko M, Yang W, Matsumoto Y, Watt F, Funa K.

Exp Cell Res. 2006 Jul 1;312(11):2028-39. Epub 2006 Apr 19.

PMID:
16624290
[PubMed - indexed for MEDLINE]
4.

In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.

Lutz W, Schwab M.

Oncogene. 1997 Jul 17;15(3):303-15.

PMID:
9233765
[PubMed - indexed for MEDLINE]
Free Article
5.

Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.

Sivak LE, Tai KF, Smith RS, Dillon PA, Brodeur GM, Carroll WL.

Oncogene. 1997 Oct 16;15(16):1937-46.

PMID:
9365240
[PubMed - indexed for MEDLINE]
Free Article
6.

Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.

Wada RK, Seeger RC, Reynolds CP, Alloggiamento T, Yamashiro JM, Ruland C, Black AC, Rosenblatt JD.

Oncogene. 1992 Apr;7(4):711-7.

PMID:
1565467
[PubMed - indexed for MEDLINE]
7.

Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.

Iyengar RV, Pawlik CA, Krull EJ, Phelps DA, Burger RA, Harris LC, Potter PM, Danks MK.

Cancer Res. 2001 Apr 1;61(7):3045-52.

PMID:
11306486
[PubMed - indexed for MEDLINE]
Free Article
8.

Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.

Ichimiya S, Nimura Y, Seki N, Ozaki T, Nagase T, Nakagawara A.

Med Pediatr Oncol. 2001 Jan;36(1):132-4.

PMID:
11464865
[PubMed - indexed for MEDLINE]
9.

Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.

Liu T, Tee AE, Porro A, Smith SA, Dwarte T, Liu PY, Iraci N, Sekyere E, Haber M, Norris MD, Diolaiti D, Della Valle G, Perini G, Marshall GM.

Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18682-7. Epub 2007 Nov 14. Erratum in: Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):21021.

PMID:
18003922
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.

Kim MK, Carroll WL.

Cancer. 2004 Nov 1;101(9):2106-15.

PMID:
15382088
[PubMed - indexed for MEDLINE]
Free Article
11.

N-myc modulates expression of p73 in neuroblastoma.

Zhu X, Wimmer K, Kuick R, Lamb BJ, Motyka S, Jasty R, Castle VP, Hanash SM.

Neoplasia. 2002 Sep-Oct;4(5):432-9.

PMID:
12192602
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.

Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.

Cancer Res. 2001 Feb 1;61(3):1073-9.

PMID:
11221835
[PubMed - indexed for MEDLINE]
Free Article
13.

Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.

Cetinkaya C, Hultquist A, Su Y, Wu S, Bahram F, PĂ„hlman S, Guzhova I, Larsson LG.

Mol Cancer Ther. 2007 Oct;6(10):2634-41.

PMID:
17938259
[PubMed - indexed for MEDLINE]
Free Article
14.

N-MYC regulates focal adhesion kinase expression in human neuroblastoma.

Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM.

J Biol Chem. 2007 Apr 27;282(17):12503-16. Epub 2007 Feb 27.

PMID:
17327229
[PubMed - indexed for MEDLINE]
Free Article
15.

The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.

Zhang Y, Sif S, DeWille J.

J Cell Biochem. 2007 Dec 1;102(5):1256-70.

PMID:
17471507
[PubMed - indexed for MEDLINE]
16.

A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells.

Poulsen TT, Pedersen N, Juel H, Poulsen HS.

Cancer Gene Ther. 2008 Sep;15(9):563-75. doi: 10.1038/cgt.2008.24. Epub 2008 Apr 18.

PMID:
18421308
[PubMed - indexed for MEDLINE]
17.

A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cells.

Meyuhas R, Pikarsky E, Tavor E, Klar A, Abramovitch R, Hochman J, Lago TG, Honigman A.

Mol Cancer Res. 2008 Sep;6(9):1397-409. doi: 10.1158/1541-7786.MCR-07-2086.

PMID:
18819928
[PubMed - indexed for MEDLINE]
Free Article
18.

The upstream region of the mouse N-myc gene: identification of an enhancer element that functions preferentially in neuroblastoma IMR32 cells.

Imamura Y, Iguchi-Ariga SM, Ariga H.

Biochim Biophys Acta. 1992 Sep 24;1132(2):177-87.

PMID:
1327147
[PubMed - indexed for MEDLINE]
19.

Cyclic AMP response element-binding protein (CREB) and CAAT/enhancer-binding protein beta (C/EBPbeta) bind chimeric DNA sites with high affinity.

Flammer JR, Popova KN, Pflum MK.

Biochemistry. 2006 Aug 8;45(31):9615-23.

PMID:
16878996
[PubMed - indexed for MEDLINE]
20.

N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma.

Hatzi E, Murphy C, Zoephel A, Ahorn H, Tontsch U, Bamberger AM, Yamauchi-Takihara K, Schweigerer L, Fotsis T.

Eur J Biochem. 2002 Aug;269(15):3732-41.

PMID:
12153570
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk